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OBJECTIVES The goal of this study was to determine whether women undergoing contemporary
percutaneous coronary intervention (PCI) remain at increased risk in comparison with men
and whether the outcomes in women have improved.
BACKGROUND Previous studies have shown that women treated with coronary angioplasty have a higher
incidence of procedural morbidity and mortality than men.
METHODS Gender differences in wave 1 of the National Heart, Lung and Blood Institute (NHLBI)
Dynamic registry were evaluated. Baseline characteristics and outcomes in women in the
Dynamic registry were compared with those in women in the 1985–1986 and 1993–1994
NHLBI Percutaneous Transluminal Coronary Angioplasty (PTCA) registries.
RESULTS Women were older with a higher prevalence of diabetes mellitus, hypertension, congestive
heart failure, unstable angina and single vessel disease in comparison with men. Although
procedural success and in-hospital death (2.2% vs. 1.3%), myocardial infarction (MI) (2.3%
vs. 3.0%) and coronary artery bypass graft surgery (CABG) (1.3% vs. 1.4%) were similar in
women and men, respectively, one-year mortality (6.5% vs. 4.3%, p  0.02) and combined
end point of death/MI/CABG (18.3% vs. 14.4%, p  0.03) were higher in women than in
men. After controlling for other factors, gender was not a significant predictor of death or
death plus MI at one year. Despite a higher risk profile in women in the Dynamic registry in
comparison with women in the 1985–1986 NHLBI PTCA registry, in-hospital death/MI/
CABG was lower (6.0% vs. 11.6%, p  0.001).
CONCLUSIONS Despite persistent high-risk characteristics in women, gender differences in outcomes in
patients undergoing contemporary PCI have decreased, and outcomes in women have
improved. (J Am Coll Cardiol 2002;39:1608–14) © 2002 by the American College of
Cardiology Foundation
Previous studies examining gender differences in patients
undergoing coronary angioplasty have reported that women
had a higher in-hospital mortality and were at increased risk
for an adverse outcome in comparison with men (1–5). This
difference in mortality was attributed, in part, to the
advanced age, risk profile and comorbid disease in women.
More recently, it was demonstrated that, in the confines of
a randomized trial comparing coronary balloon angioplasty
and coronary bypass surgery in patients with multivessel
disease, women and men undergoing coronary angioplasty
had a similar mortality in-hospital and at five years (6).
Furthermore, single center reports as well as registry expe-
rience have noted an improved outcome in women treated
with coronary balloon angioplasty (7–10). However, the
influence of advances in technique and technology, partic-
ularly in the use of intracoronary stents and adjunctive
antiplatelet agents on the outcome of coronary intervention
in women has not yet been well defined. Accordingly, we
examined the gender differences in patients undergoing
contemporary percutaneous coronary intervention (PCI) in
a multicenter registry experience.
METHODS
Registry design and patient population. The National
Heart, Lung, and Blood Institute (NHLBI) funded Dy-
namic registry includes 15 clinical centers and a coordinat-
ing center located at the University of Pittsburgh Graduate
School of Public Health. Of the clinical centers, 11 were
participants in the 1985–1986 and 1993–1994 (the latter
time period open to women only) Percutaneous Translumi-
nal Coronary Angioplasty (PTCA) registries. Four centers
were added to increase enrollment of minorities. The
Dynamic registry is designed to evaluate three separate
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cohorts of approximately 2,000 patients, 18 months apart.
Importantly, at each site, a recruitment cap on white men
was instituted, so as to augment the enrollment of women
and minorities. The first wave of the registry began in July
1997 and was completed in February 1998, and all regis-
tered patients are included in this report. The protocol was
approved by each institution’s review board, and informed
consent to collect information after hospital discharge was
obtained.
Data collection and management. Data collected in-
cluded demographic information, medical history and risk
factor status. Detailed coronary angiographic information
before and after coronary intervention and left ventricular
ejection fraction were obtained as were procedural strategy
and procedural success of each significant (50%) coronary
artery lesion attempted. Angiograms were interpreted at the
clinical sites. Procedural outcome in terms of success and
major in-hospital complications (death, nonfatal infarction,
emergency coronary bypass surgery) as well as in-hospital
untoward events were recorded. At one-year follow-up, the
information collected included vital status, presence and
type of angina, medications and intercurrent hospitalization
for myocardial infarction (MI), repeat PCI or coronary
artery bypass graft surgery (CABG).
Definitions. Death was defined as mortality from any
cause. Myocardial infarction was defined as evidence of two
or more of the following: 1) typical chest pain 20 min
duration not relieved by nitroglycerin; 2) serial electrocar-
diogram recordings showing changes from baseline or seri-
ally in ST-T and/or Q-waves in two or more contiguous
leads; 3) serum enzyme elevation of creatine phosphokinase
(CPK)-myocardial band 5% of total CPK, total CPK
2 normal, lactic dehydrogenase (LDH)-1 greater than
LDH-2 or troponin 0.2 g/ml; and 4) new wall motion
abnormalities. Angiographic success was defined as an
absolute 20% reduction in lesion severity and a final stenosis
of 50%. Angiographic success was classified as either
partial, when at least one lesion was successfully treated, or
total, when all attempted lesions were successfully treated.
Coronary artery bypass graft surgery was classified as elec-
tive, urgent or emergency according to clinical circum-
stances. Procedural success was defined as either partial or
total angiographic success without death, Q-wave MI or
emergency CABG.
Data analysis. Women and men were compared according
to demographics, baseline history, risk factors, angiographic
and procedural characteristics, initial success and complica-
tions and in-hospital outcomes using the chi-square test (or
Fisher exact test) for categorical data and the Student t test
or Wilcoxon rank-sum test for continuous data. One-year
event rates were calculated using the Kaplan-Meier method
(11) and compared using log-rank statistics. In-hospital
outcomes, including death and death plus MI and emer-
gency CABG, were modeled with logistic regression (12).
Explanatory variables considered for the models were base-
line characteristics that either were independently related to
the outcome and/or differed significantly between women
and men. Once a model was found that included only
significant predictors (p  0.10), gender was added. Cox
regression analysis was used to compare one-year outcomes
in women and men with adjustments for baseline charac-
teristics that were distributed differently for women and
men and/or related to the outcome (13).
In comparing women from the 1985–1986, 1993–1994
and Dynamic registries, a different group of women was
considered. Only patients who were enrolled consecutively
(patients enrolled before the first recruitment cap was
reached at each site) and who had not had any prior
coronary angioplasty procedure were included. This was
done because otherwise the proportion of minority patients
and, thus, the distribution of many clinical factors would not
be comparable to the earlier registries. Demographic data
and in-hospital outcomes were compared between the
1985–1986, the 1993–1994 and Dynamic registries looking
at time trends. There was no follow-up for the 1993–1994
registry, but one-year event rates were estimated for the
1985–1986 and Dynamic registries using the Kaplan-Meier
method. Logistic regression was used to compare in-
hospital outcomes for the 1985–1986 and Dynamic regis-
tries and the 1993–1994 and Dynamic registries. Cox
regression analysis was used to compare one-year outcomes
for women from the 1985–1986 and Dynamic registries
with adjustment for baseline characteristics that were dis-
tributed differently between the registries and/or were re-
lated to the outcome. Time period was used as the first
explanatory variable. Statistical significance was assumed for
p 0.05.
RESULTS
Of the 2,524 patients registered, 2,205 were consecutively
enrolled, and the remainder were women and minority
patients. Of the total 2,524 patients, 895 (35%) were
women. The proportion of women at the 15 clinical sites
ranged from 25% to 45%.
Baseline clinical and angiographic characteristics. On
average, the women were significantly older than the men
(Table 1), and a higher proportion of women than men were
Abbreviations and Acronyms
CABG  coronary artery bypass graft surgery
CI  confidence interval
CPK  creatine phosphokinase
LDH  lactic dehydrogenase
MI  myocardial infarction
NHLBI  National Heart, Lung and Blood Institute
OR  odds ratio
PCI  percutaneous coronary intervention
PTCA  percutaneous transluminal coronary
angioplasty
RR  relative risk
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black. Overall, women were significantly more likely to have
a history of diabetes mellitus, hypertension and severe
noncardiac comorbid disease. Women were more likely than
men to have single-vessel disease, and, on average, they had
fewer significant lesions and vessels that were totally oc-
cluded (Table 2). Compared with men, women’s reference
vessel size was significantly smaller although lesion length
was similar (Table 3).
Procedural characteristics. The primary reason for revas-
cularization was more likely to be unstable angina for
women than for men (Table 2). The number of multilesion
attempts was similar for women and men although women
were less commonly treated with a IIb/IIIa platelet receptor
antagonist than men. Women were less likely to receive a
stent. On a lesion level, initial and final percent stenosis and
lesion success did not differ significantly by gender. Differ-
ence in stent use was not statistically significant, on a lesion
level, once reference vessel size was taken into consideration.
Adverse events and in-hospital outcomes. There were no
differences in procedural complications, including the inci-
dence of coronary dissection and abrupt vessel closure,
between women and men with the exception of major entry
site complications (5.0% vs. 2.6%, p  0.001) and bleeding
requiring transfusion (3.2% vs. 1.1%, p  0.001), which
occurred more frequently in women than in men. Proce-
dural success was similar between genders. Of note, there
were no significant differences in unadjusted rates for
in-hospital death, MI, CABG or the combined outcome of
death, MI and emergency CABG between women and men
(Table 4). Female gender was not a significant predictor of
in-hospital death (odds ratio [OR]  1.60, 95% confidence
interval [CI] 0.76, 3.35) or death plus MI and emergency
CABG (OR 1.15, 95% CI 0.74, 1.79) after controlling
for other significant factors.
Outcomes at one year. At one year after the procedure,
mortality was significantly higher (6.5% vs. 4.3%, p  0.02)
(Fig. 1). However, after controlling for other significant
factors, gender was not a significant predictor of death
(relative risk [RR]  1.26, 95% CI  0.85, 1.87) or death
plus MI (RR  1.14, 95% CI  0.86, 1.50). The combined
end point of death plus MI and CABG occurred signifi-
cantly more frequently in women than in men (Table 5), but
this difference did not appear until approximately 90 days
after the procedure. During the first 90 days, women and
men had similar rates for the combined outcome (Kaplan-
Meier estimates for cumulative rates at 90 days 8.8% for
women vs. 8.5% for men, p  0.859).
Comparison of the registries. Table 6 depicts the demo-
graphic data and event rates between women in the 1985–
1986, 1993–1994 and Dynamic registries. Women in the
Dynamic registry were older with more comorbid disease,
diabetes mellitus, hypertension, hypercholesterolemia and
more multivessel disease than women in the earlier regis-
tries. Yet, in-hospital mortality was similar and angio-
graphic and procedural success higher in the Dynamic
registry in comparison with the 1985–1986 and 1993–1994
registries. Unadjusted one-year event rates did not differ
between the Dynamic registry and the 1985–1986 registry,
with the exception of a lower repeat revascularization rate in
the Dynamic registry. However, after adjustment for base-
line characteristics, the Dynamic registry time period was a
significant independent predictor of a lower mortality
(RR  0.51, 95% CI  0.29 to 0.90) at one year in
comparison with the 1985–1986 registry time period.
Table 1. Baseline Clinical Characteristics by Gender From the 1997–1998 Dynamic Registry
Men
(n  1,629)
Women
(n  895) p Value
Demographics
Mean age (yrs) 60.7  11.4 66.1  11.4 0.001
Age 65 yrs (%) 37.2 57.9 0.001
Race (%) 0.001
White 80.8 79.3
Black 5.8 11.2
Asian 5.3 4.0
Hispanic 8.1 5.5
Height (cm) 174.2  7.9 160.5  6.9 0.001
Weight (kg) 85.3  15.5 73.4  15.6 0.001
Body mass index (kg/m2) 28.1  4.6 28.5  5.8 0.416
Medical history
Prior percutaneous procedure(s) (%) 29.0 25.9 0.091
Prior CABG (%) 17.7 13.8 0.013
Prior myocardial infarction (%) 40.7 36.3 0.030
History of diabetes (%) 23.7 35.8 0.001
Insulin (%) 5.9 13.7 0.001
History of CHF (%) 8.5 12.8 0.001
History of hypertension (%) 54.3 68.7 0.001
History of hypercholesterolemia (%) 60.1 62.7 0.226
Current smoker (%) 27.9 20.6 0.001
Severe noncardiac concomitant disease (%) 27.4 33.7 0.001
CABG  coronary artery bypass surgery; CHF  congestive heart failure.
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Table 2. Patient Angiographic and Procedural Characteristics by Gender From the 1997–1998
Dynamic Registry
Men
(n  1,629)
Women
(n  895) p Value
LVEF
Mean LVEF (%) (938 men; 510 women) 54.1  14.4 56.3  13.6 0.011
Abnormal LVEF (%) (1,055 men; 594 women) 30.1 22.6 0.001
Vessel disease (%) 0.025
Single 40.1 45.7
Double 33.0 30.1
Triple 26.9 24.2
Any total occlusion (%) 42.4 34.1 0.001
Mean number significant lesions 2.9  2.1 2.7  2.0 0.004
Primary reason for revascularization (%) 0.055
Asymptomatic coronary artery disease 2.4 1.7
Stable angina 25.9 22.8
CCSC I/II 12.1 10.1 0.126
CCSC III/IV 13.0 12.5 0.764
Unstable angina 44.8 50.6
Acute myocardial infarction 19.5 18.7
Cardiogenic shock 1.8 1.6 0.614
Thrombolytic therapy 5.0 4.0 0.281
Other 7.4 6.2
Medication 24 h before or during procedure (%)
Ticlopidine 51.0 47.7 0.119
IIb/IIIa receptor antagonist 26.5 20.4 0.001
Number of lesions attempted
2 or more (%) 33.6 31.5 0.289
(Mean) 1.5  0.8 1.4  0.7 0.142
Number of vessels attempted
2 or more (%) 10.0 7.8 0.075
Graft attempted (%) 8.6 5.2 0.002
Lesion with total occlusion attempted (%) 20.9 15.6 0.001
Balloon only/balloon  local drug (%) 24.1 28.9 0.007
RA use overall (%) 10.4 15.3 0.001
Stent use overall (%) 70.0 62.7 0.001
CCSC  Canadian Cardiovascular Society Classification; LVEF  left ventricular ejection fraction; RA  rotational
atherectomy.
Table 3. Attempted Lesion Characteristics by Gender From the 1997–1998 Dynamic Registry
Men Women p Value
Total attempted lesions n  2,373 n  1,250
Reference vessel size (mm) 3.09  0.95 2.90  0.58  0.001
Lesion length (mm) 12.49  8.02 12.14  7.22 0.770
Lesion characteristics (%)
Total occlusion 15.5 12.5 0.015
Evidence of thrombus 20.5 17.9 0.066
Calcified 29.2 30.7 0.352
Ulcerated 13.7 10.3 0.004
Bifurcation 12.6 11.7 0.453
Receive collateral 13.8 12.5 0.322
Supply collateral 6.0 4.5 0.081
Ostial lesion 7.9 10.0 0.029
Mean diameter % stenosis 84.5  14.1 84.1  14.4 0.428
Final % stenosis 11.7  20.5 11.3  19.0 0.418
Lesion success (%) 93.8 94.3 0.569
Device usage (%)  0.001
Balloon only/balloon  local drug 32.1 36.1
Balloon  RA/RA only 4.2 6.1
Balloon  stent/stent only 55.7 48.3
Balloon  RA  stent 5.2 7.0
Other combinations 2.8 2.6
RA  rotational atherectomy.
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DISCUSSION
Although early studies evaluating gender differences in
patients undergoing coronary revascularization noted a sig-
nificantly worse outcome and higher mortality in women in
comparison with men (1–5), more recent reports suggest
that the differences in outcome between women and men
treated with coronary balloon angioplasty have decreased
and that the overall outcomes in women have improved
(6–9). However, because the prevalence of coronary artery
disease is lower in women than in men, the number of
women studied has necessarily been limited, and the influ-
ence of new technology and adjunctive pharmacology in
women undergoing PCI has been difficult to capture in the
rapidly changing field of interventional cardiology.
The design and concept of the Dynamic registry, which
enrolls consecutive patients at multiple centers, with an
added sample of women and minorities and with the ability
to compare three sets of patients over time, allows a more
thorough evaluation of the influence of contemporary prac-
tice on outcome. Our sites are geographically diverse with
U.S. sites in the Northeast, Mid-Atlantic, South, Midwest
and West Coast, a Canadian site in Montreal and a
European site in Prague, Czech Republic. While the ma-
jority of our sites are from academic institutions, we also
include four community practices. To date, the results of the
present study of the first wave of patients are encouraging
and suggest that, despite the persistent and well-recognized
baseline gender differences in patients with coronary artery
disease, the outcomes of contemporary PCI in women have
improved.
Baseline clinical, angiographic and procedural character-
istics. Because the age at clinical presentation of coronary
artery disease in women lags 10 to 20 years behind that in
men (14), women continue to be older than men when they
are in need of revascularization, and this observation is once
again supported by the older age of women in this registry.
Women are generally smaller than men, and this difference
in body size, a surrogate for coronary vessel diameter, has
been thought to influence in-hospital outcome, particularly
in patients treated with CABG (15,16). It has been postu-
lated that advances in technology leading to smaller guiding
and balloon catheters would result in a more favorable
outcome in women, and this is supported by the similar
lesion, angiographic and procedural success rates between
women and men seen in this study, despite the smaller
reference vessel size in women.
Similar to earlier reports, women had a higher prevalence
of risk factors such as diabetes mellitus, hypertension and
hypercholesterolemia (although a lower prevalence of cur-
rent smoking, previously shown to be related to older age) in
comparison with men (1,2). Yet, the extent of epicardial
vessel disease was less in women than in men and whether
this observation suggests that the traditional risk factors are
less potent in women is unclear. Furthermore, despite the
lower incidence of previous MI and better preserved systolic
left ventricular function in women in comparison with men,
the incidence of congestive heart failure was once again
higher in women than in men. A higher incidence of
hypertensive heart disease, a steeper pressure volume rela-
tionship, and more diastolic dysfunction in women in
comparison with men has been thought to account for this
observation (17–19).
Women were less likely to receive treatment with IIb/IIIa
platelet receptor antagonists than men, and this may reflect
the lower incidence of ulcerated lesions in women. Similar
to the reason for the decreased use of stents in women is the
reason for the increased use of rotational atherectomy in
Table 5. Status at One Year by Gender for the 1997–1998
Dynamic Registry
Men Women p Value
Death (%) 4.3 6.5 0.022
MI (%) 5.5 5.5 0.925
CABG (%) 6.4 8.7 0.048
Repeat PCI (%) 14.0 15.9 0.244
Death/MI (%) 9.0 11.1 0.135
Death/MI/CABG (%) 14.4 18.3 0.027
CABG/repeat PCI (%) 19.0 22.5 0.072
Angina status (%) (n  1,999)  0.001
No angina, nitrates not used 61.6 51.9
No angina, nitrates used 14.8 18.2
Angina 23.6 29.8
CABG  coronary artery bypass surgery; MI  myocardial infarction; PCI 
percutaneous coronary intervention.
Table 4. In-Hospital Outcomes by Gender From the 1997–
1998 Dynamic Registry
Men
(n  1,629)
Women
(n  895) p Value
Total angiographic success (%) 91.9 92.7 0.450
Procedural success (%) 95.0 94.2 0.372
Death (%) 1.3 2.2 0.072
Stroke (%) 0.2 0.7 0.181
MI (%) 3.0 2.3 0.333
Q-wave (%) 0.2 0.7 0.104
Enzymes 2 normal (%) 2.6 2.1 0.422
CABG (%) 1.4 1.3 0.991
Death/any MI/E CABG (%) 4.5 4.8 0.711
CABG  coronary artery bypass surgery; E  emergency; MI  myocardial
infarction.
Figure 1. One-year survival rates by gender.
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women in comparison with men, which likely reflects
smaller vessel size in women. Furthermore, after adjusting
for reference vessel size, stent use was similar for the two
genders. It is noteworthy, however, that stents were used in
over 50% of lesions in this 1997–1998 experience, and the
favorable influence of the increased use of stents on overall
angiographic success and subsequent revascularization has
been reported (20).
Outcomes in-hospital and at one year. Although it is
natural to relate the similar and improved angiographic and
procedural success rates to the similar death, MI and
emergency CABG rates between women and men, it is
important to recall that in-hospital death was 10-fold higher
in women than in men (despite a similar angiographic and
procedural success rate) in the 1985–1986 registry report
(2). Although the expected risk factors for mortality such as
age, cardiogenic shock and congestive heart failure were
independent predictors of in-hospital death, female gender
was not independently and significantly related to in-
hospital mortality after controlling for other factors. Given
the small number of mortal events in the Dynamic registry
(41 deaths), it is possible that this negative finding is due to
a lack of statistical power. However, while our findings are
consistent with a slightly higher risk for in-hospital mortal-
ity for women compared with men, they clearly show that
the differences are much smaller than they were 10 years
ago. Our results are also consistent with those published
from the National Cardiovascular Network, a large-scale
registry of patients undergoing PCI between 1994 to 1997.
In-hospital mortality was significantly higher in women in
comparison with men, but mortality risk was similar in
women and men after adjustment for baseline differences
(10). Furthermore, the lack of a gender difference in the
combined end point of death, MI and emergency CABG
(116 events) in the present study is reassuring.
Although the death rate at one year was higher in women
than in men, female gender again did not independently
predict mortality. Repeat revascularization was slightly, but
not significantly, higher in women than in men at one year,
and female gender was associated with an increase in risk for
the combined end point of death, MI and CABG. The less
frequent use of stents in women may relate to the need for
subsequent revascularization.
Comparison of the registries. Artificial comparisons be-
tween the young and the elderly, between patients of
different race and between women and men continue to be
Table 6. Demographic Data and Event Rates of Women by Registry Time Period
1985–1986 1993–1994 Dynamic 1997–1998 p Value
Total patients (women) n  620 n  436 n  500
Demographic data
Mean age (yrs) 61.8  11.0 65.0  11.5 66.0  11.4  0.001
White (%) 86.1 84.4 82.0 0.072
Black (%) 7.6 7.3 10.2 0.128
Concomitant disease (%) 9.5 17.9 31.8  0.001
History of diabetes (%) 20.3 32.4 33.8  0.001
History CHF (%) 9.0 15.2 10.7 0.295
History of hypertension (%) 57.7 62.0 66.3 0.003
History of hypercholesterolemia (%) 38.0 40.8 59.5  0.001
Prior MI (%) 35.5 28.9 29.5 0.025
Prior CABG (%) 9.2 11.0 9.8 0.689
Acute MI (%) 8.6 25.0 23.6  0.001
Evidence of calcified lesion (%) 13.9 16.5 31.1  0.001
Evidence of thrombus (%) 13.9 17.9 24.4  0.001
Multivessel disease (%) 49.4 52.1 57.8 0.005
Presence of total occlusion (%) 30.8 32.1 33.8 0.287
Number of significant lesions (mean) 2.52  1.76 2.39  1.81 2.52  1.87 0.969
Number of lesions attempted (mean) 1.51  0.87 1.30  0.62 1.37  0.69 0.002
In-hospital events
Death (%) 3.2 2.3 3.0 0.784
Death/MI/E CABG (%) 9.8 6.7 5.2 0.003
Death/MI/CABG (%) 11.6 8.0 6.0  0.001
Total angiographic success (%) 85.2 89.0 93.8  0.001
Procedural success (%) 84.7 89.0 92.2  0.001
One-year events
Death (%) 5.8 7.4 0.314
MI (%) 6.8 5.6 0.309
CABG (%) 12.2 9.5 0.080
Repeat PCI (%) 16.6 14.7 0.454
Death/MI (%) 10.8 11.9 0.701
Death/MI/CABG (%) 18.3 19.4 0.906
CABG/repeat PCI (%) 26.9 21.9 0.030
CABG  coronary artery bypass surgery; CHF  congestive heart failure; E  emergency; MI  myocardial infarction; PCI 
percutaneous coronary intervention.
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made for the purpose of focusing on higher-risk subsets of
patients. Because women will no doubt continue to be at
higher risk than men for revascularization based on ad-
vanced age and comorbid disease, it is important to compare
the outcome in women over time. Examination of the
1985–1986 and 1993–1994 NHLBI PTCA registries allows
us to do so. Despite older women with a higher prevalence
of risk factors and concomitant disease in the Dynamic
registry, in-hospital and one-year mortality was similar in
women in the Dynamic registry and the earlier registries and
the incidence of repeat revascularization at one year signif-
icantly lower in the Dynamic registry in comparison with
the 1985–1986 registry. In addition, compared with the
1985–1986 registry time period, the Dynamic registry time
period was a significant predictor of lower mortality at one
year after adjusting for baseline differences between women
in the two registries.
These data suggest that the gender differences in out-
comes in patients undergoing contemporary PCI have
decreased and that the outcomes in women undergoing
these procedures have improved. Whether these more
favorable results in women are due to the focus on women’s
health issues in general, or on women and heart disease in
particular, or to the increasing appreciation of the issues
specific to women or to the increased use of stents and
adjunctive pharmacologic agents is unclear. However, it is
important to note that women in need of coronary revas-
cularization who are candidates for a PCI should be referred
for the procedure with the expectation of an excellent
outcome, which is no longer associated with undue risk.
Reprint requests and correspondence: Dr. Alice K. Jacobs,
Section of Cardiology, Boston Medical Center, 88 East Newton
Street, Boston, Massachusetts 02118. E-mail: alice.jacobs@bmc.org.
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